Related Experiment Video
Updated: Jan 28, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
New Hope in Prostate Cancer Precision Medicine? miRNA Replacement and Epigenetics
1Department of Translational Medicine, Division of Urological Cancers, Lund University, and the Department of Urology, Skåne University Hospital, Malmö, Sweden. anders.bjartell@med.lu.se.
Abstract:
SPINK1 +/ETS - prostate cancer is an aggressive disease with poor clinical outcome. New data suggest a novel treatment by upregulating the expression of miR-338-5p/-421 through epigenetic modulation or by miRNA replacement. This is a new and interesting concept that warrants further exploration in clinical trials.See related article by Bhatia et al., p. 2755.
Insights
SPINK1-positive/ETS-negative prostate cancer is aggressive. Upregulating miR-338-5p/-421 via epigenetic modulation or miRNA replacement offers a novel therapeutic strategy for this condition.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- SPINK1-positive/ETS-negative prostate cancer is characterized by aggressive behavior and poor clinical outcomes.
- Identifying novel therapeutic targets is crucial for improving patient prognosis in this specific prostate cancer subtype.
Purpose of the Study:
- To explore a novel therapeutic strategy for SPINK1-positive/ETS-negative prostate cancer.
- To investigate the potential of modulating miR-338-5p and miR-421 expression as a treatment approach.
Main Methods:
- The study focuses on epigenetic modulation to upregulate specific microRNAs.
- Alternative methods discussed include direct miRNA replacement therapy.
Main Results:
- New data suggest that upregulating miR-338-5p and miR-421 can be a potential therapeutic avenue.
- This approach targets the molecular mechanisms underlying the aggressive nature of this cancer subtype.
Conclusions:
- Upregulating miR-338-5p/-421 presents a promising novel treatment concept for SPINK1-positive/ETS-negative prostate cancer.
- Further clinical trials are warranted to validate this epigenetic or miRNA replacement strategy.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Uncertainty in Measurement: Accuracy and Precision
Continuous Renal Replacement Therapy
Microorganisms in Medicine and Therapeutics
Accuracy and Precision

